BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10417558)

  • 21. Indigenous cost-effective peritoneo-venous shunt for refractory ascites.
    Marimuthu K; Kumar AS; Sabanathan S; Gowrishankar A; Kumar PS; Rajkumar JS
    Int Surg; 2004; 89(2):85-9. PubMed ID: 15285240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
    Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal venous shunting for ascites: a 15-year perspective.
    Hyde GL; Dillon M; Bivins BA
    Am Surg; 1982 Mar; 48(3):123-7. PubMed ID: 7073133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with saphenous-peritoneal shunts in the treatment of intractable ascites].
    Vizsy L; Beznicza H; Bátorfi J
    Orv Hetil; 2004 Feb; 145(9):479-81. PubMed ID: 15077480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alternative options for examination of the patency of peritoneo-venous shunts].
    Arató E; Kollár L; Szilágyi K; Litter I; Schmidt E
    Magy Seb; 2004 Feb; 57(1):31-6. PubMed ID: 15270521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneovenous shunts--devices of last resort.
    Shepherd KE; Miller BJ
    Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory ascites.
    Runyon BA
    Semin Liver Dis; 1993 Nov; 13(4):343-51. PubMed ID: 8303315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the Leveen shunt in the treatment of clinically intractable ascites].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; Arab-Fadul R; Gama-Rodrigues JJ
    Arq Gastroenterol; 1988; 25(3):138-44. PubMed ID: 3255281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sapheno-peritoneal shunt for the treatment of ascites].
    Nagy Z; Gyurkovics E; Kaliszky P; Kupcsulik P
    Magy Seb; 2001 Aug; 54(4):235-8. PubMed ID: 11550492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of peritoneal venous shunting for intractable neonatal ascites: a short case series.
    Herman R; Kunisaki S; Molitor M; Gadepalli S; Hirschl R; Geiger J
    J Pediatr Surg; 2011 Aug; 46(8):1651-4. PubMed ID: 21843738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantation of a skin graft tube to create a saphenoperitoneal shunt for refractory ascites.
    Lasheen AE; Elzeftawy A; Ibrahim S; Attia M; Emam M
    Surg Today; 2007; 37(7):622-5. PubMed ID: 17593487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of the peritoneovenous shunt for the management of intractable ascites.
    Fry PD; Hallgren R; Robertson ME
    Can J Surg; 1979 Nov; 22(6):557-9. PubMed ID: 497929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M; Maetani I; Sakai Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of ascites with peritoneovenous shunting: a study of clinical management.
    Schumann D
    Heart Lung; 1983 May; 12(3):248-55. PubMed ID: 6551372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.